Your session is about to expire
← Back to Search
Prednisone for Long QT Syndrome
Study Summary
This trial aims to find out if there's a connection between anti-Ro/SSA antibodies and an acquired prolongation of the QT interval in people with connective tissue disease.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2016 Phase 3 trial • 854 Patients • NCT00003389Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are a patient with connective tissue disease and are enrolled in New York Harbor Healthcare System.I have atrial fibrillation.I have or my family has a history of heart rhythm problems or untreated thyroid issues.I have a lower than normal body temperature.You have a delay in the electrical signals in your heart, which causes a wide QRS complex on an electrocardiogram.You have taken too much of the study drug or any other medication.
- Group 1: Prednisone Group
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is there an age threshold for inclusion in this experiment?
"To be eligible for this clinical study, participants must between 18 and 89 years old."
Is it feasible for me to join this research initiative?
"Those with rheumatoid arthritis between the ages of eighteen and eighty-nine can be accepted into this medical experiment, which is looking to enrol 25 individuals."
Has the FDA sanctioned Prednisone for clinical use?
"Given the Phase 4 status of this treatment, our internal team at Power has assigned Prednisone a safety rating of 3. This implies that there is an abundance of data supporting its effectiveness and efficacy."
What conditions commonly respond to Prednisone treatment?
"Prednisone is regularly used to treat thyroiditis and other medical complications like varicella-zoster virus acute retinal necrosis, malignant neoplasms, and ulcerative colitis."
What research has been conducted in regard to Prednisone's efficacy?
"At the moment, 334 Prednisone clinical trials are in progress and 92 of them have reached Phase 3. While there is a notable concentration of research sites located in Duarte, California, 16404 different locations globally are participating in these studies."
Is this research currently seeking participants?
"Affirmative, the details on clinicaltrials.gov indicate that this trial is currently recruiting participants. This study was initially posted on September 28th 2011 and was updated most recently on April 7th 2022; it aims to include 25 individuals at a solitary centre."
How many subjects are partaking in this experiment?
"Affirmative, according to the details posted on clinicaltrials.gov this research study is open for enrollment. The initial posting was made on September 28th 2011 and has been updated as recently as April 7th 2022. 25 participants are needed from 1 centre in total."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger